LIVE/VIRTUAL ACTIVITIES

Bio Ascend – Designing CME Solutions For a Virtual World, Our Live and Virtual CME Activities Are Designed to Keep HCPs Educated.

Bio Ascend helps healthcare providers (HCPs) like you stay educated by providing the CME resources you need for continuing education. Our vast selection of activities is devoted entirely to solid tumor and hematologic malignancies – with engaging options in both in-person and virtual environments. Activities feature leading experts discussing the latest data and how to apply it to clinical practice, providing you with critical insight and direction on how to incorporate therapeutic advancements into your practice.

Satellite Symposia:
Practical Aspects of Incorporating CAR T-Cell Therapy into Your Practice

June 23, 2021 – Virtual
Time: 7:00 PM – 9:00 PM EST

There are no fees to register for this symposium

This live-streamed independent satellite symposium will take place following the #ASCO21 meeting and will be presented on an interactive web platform by 3 renowned experts actively engaged in the use of CAR T-cell therapies for patients with lymphoma and multiple myeloma.

Be sure to check back in July to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summary of the symposium’s take-home messages most relevant to practice and clinical decision making.

Agenda
7:00PM
Welcome, Introductions, and Pre-session Survey
7:10PM

Overview of CAR T-cell Therapy

  • CAR T-cell mechanism of action
  • Treatment process
7:25PM

Clinical experience with CAR T-cell therapy for lymphoma and myeloma

  • CD19-targeting
  • BCMA-targeting
7:55PM

How to manage novel AE profiles

  • Cytokine release syndrome
  • Neurotoxicity
8:20PM

Practical aspects of CAR T-cell therapy

  • Choosing the right patient for CAR T-cell therapy
  • Optimizing the referral process and multdisciplinary care
8:40PM
Panel Discussion and Audience Q&A
8:50PM
Recap of Key Points and Post-Session Survey
9:00PM
Program Adjourns
IMG 6263

Symposium Chair

Sagar Lonial, MD, FACP Winship Cancer Institute of Emory University

Faculty

Joseph Mikhael, MD, MEd, FRCPC, FACP
Translational Genomics Research Institute (TGen), City of Hope Cancer Center
International Myeloma Foundation

Krina Patel, MD, MSc
The University of Texas
MD Anderson Cancer Center

Satellite Symposia:
Practical Aspects of Incorporating
CAR T-Cell Therapy into Your Practice

June 23, 2021 – Virtual
Time: 7:00 PM – 9:00 PM EST23

IMG 6263

Click the registration button below to see the expert presenters and the agenda
There are no fees to register for this symposium

This live-streamed independent satellite symposium will take place following the #ASCO21 meeting and will be presented on an interactive web platform by 3 renowned experts actively engaged in the use of CAR T-cell therapies for patients with lymphoma and multiple myeloma.

Be sure to check back in July to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summary of the symposium’s take-home messages most relevant to practice and clinical decision making.

Symposium Chair

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University

Faculty

Joseph Mikhael, MD, MEd, FRCPC, FACP
Translational Genomics Research Institute (TGen), City of Hope Cancer Center
International Myeloma Foundation

Krina Patel, MD, MSc
The University of Texas
MD Anderson Cancer Center

Agenda
7:00 PM
Welcome, Introductions, and Pre-session Survey
7:10 PM

Overview of CAR T-cell Therapy

  • CAR T-cell mechanism of action
  • Treatment process
7:25 PM

Clinical experience with CAR T-cell therapy for lymphoma and myeloma

  • CD19-targeting
  • BCMA-targeting
7:55 PM

How to manage novel AE profiles

  • Cytokine release syndrome
  • Neurotoxicity
8:20 PM

Practical aspects of CAR T-cell therapy

  • Choosing the right patient for CAR T-cell therapy
  • Optimizing the referral process and multdisciplinary care
8:40 PM
Panel Discussion and Audience Q&A
8:50 PM
Recap of Key Points and Post-Session Survey
9:00 PM
Program Adjourns